| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K52037352 |
| PharmacoGx | BRD-K52037352 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHLDA3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | GCH1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | S100A1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | C11orf49 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | ZNF529 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | ONECUT2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | RABEP2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | RRAS | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | FAM46C | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | MYT1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
